DeLong Mark Jeffrey — Chief Business & Strat Officer
Insider trading activity for DeLong Mark Jeffrey sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Business & Strat Officer
- Company: Apellis Pharmaceuticals, Inc.
- Total insider trades: 21
- Total buy volume: $0
- Total sell volume: $0
- Last trade: May 14, 2026
Recent Trades
| Date | Insider | Ticker / Company |
Type | Shares | Value |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
24,666 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
30,845 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
6,952 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
30,000 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
18,750 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
27,224 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
14,799 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
82,500 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
21,381 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
8,482 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
4,909 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
36,606 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
18,303 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
BUY |
18,303 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
36,606 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
BUY |
36,606 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
19,006 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
BUY |
19,006 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
SELL |
41,250 |
N/A |
| May 14, 2026 |
DeLong Mark Jeffrey |
APLS Apellis Pharmaceuticals, Inc. |
BUY |
41,250 |
N/A |
← All executives · Full trades feed
